Singapore markets closed
Straits Times Index
3,296.89 +4.20 (+0.13%) S&P 500
5,044.95 +26.56 (+0.53%) Dow
38,128.66 +225.37 (+0.59%) Nasdaq
15,748.19 +142.71 (+0.91%) Bitcoin USD
59,223.02 +2,115.57 (+3.70%) CMC Crypto 200
1,272.56 +1.82 (+0.14%)
Entheon Biomedical Corp. (ENTBF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
As of 09:30AM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 707.62k |
| Enterprise value | 457.49k |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 3.58 |
| Price/book (mrq) | 2.84 |
| Enterprise value/revenue | 1.83 |
| Enterprise value/EBITDA | -1.46 |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | 516.67% |
| S&P500 52-week change 3 | 23.57% |
| 52-week high 3 | 0.2000 |
| 52-week low 3 | 0.0040 |
| 50-day moving average 3 | 0.0885 |
| 200-day moving average 3 | 0.0313 |
Share statistics
| Avg vol (3-month) 3 | 9.04k |
| Avg vol (10-day) 3 | 1.76k |
| Shares outstanding 5 | 5.91M |
| Implied shares outstanding 6 | 6.37M |
| Float 8 | 4.33M |
| % held by insiders 1 | 2.14% |
| % held by institutions 1 | 0.00% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 12 Nov 2020 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in CAD.Fiscal year
| Fiscal year ends | 30 Nov 2023 |
| Most-recent quarter (mrq) | 29 Feb 2024 |
Profitability
| Profit margin | -214.29% |
| Operating margin (ttm) | -216.78% |
Management effectiveness
| Return on assets (ttm) | -36.67% |
| Return on equity (ttm) | -73.36% |
Income statement
| Revenue (ttm) | 130.32k |
| Revenue per share (ttm) | 0.02 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | N/A |
| Net income avi to common (ttm) | -279.27k |
| Diluted EPS (ttm) | -0.0400 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 249.92k |
| Total cash per share (mrq) | 0.04 |
| Total debt (mrq) | N/A |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 5.62 |
| Book value per share (mrq) | 0.04 |
Cash flow statement
| Operating cash flow (ttm) | -265.39k |
| Levered free cash flow (ttm) | -172.11k |
© 2024 Yahoo. All rights reserved.